These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29637686)

  • 1. Nordihydroguaiaretic acid can suppress progression of experimental autoimmune encephalomyelitis.
    Wang L; Li L; Quan MY; Wang D; Jia Z; Li ZF; Li B; Guo L; Tan GJ
    IUBMB Life; 2018 May; 70(5):432-436. PubMed ID: 29637686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of oxidative stress p38MAPK-SGK1 signaling axis in experimental autoimmune encephalomyelitis (EAE).
    Wang L; Li B; Quan MY; Li L; Chen Y; Tan GJ; Zhang J; Liu XP; Guo L
    Oncotarget; 2017 Jun; 8(26):42808-42816. PubMed ID: 28467798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
    Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology.
    Venkatesha SH; Moudgil KD
    Inflamm Res; 2019 Apr; 68(4):285-296. PubMed ID: 30820608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38MAPK/SGK1 signaling regulates macrophage polarization in experimental autoimmune encephalomyelitis.
    Li B; Tan TB; Wang L; Zhao XY; Tan GJ
    Aging (Albany NY); 2019 Feb; 11(3):898-907. PubMed ID: 30716717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of experimental autoimmune encephalomyelitis is associated with up-regulation of major sodium transporters in the mouse kidney cortex under a normal salt diet.
    Zhou X; Packialakshmi B; Xiao Y; Nurmukhambetova S; Lees JR
    Cell Immunol; 2017 Jul; 317():18-25. PubMed ID: 28438314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.
    Nimmagadda VK; Bever CT; Vattikunta NR; Talat S; Ahmad V; Nagalla NK; Trisler D; Judge SI; Royal W; Chandrasekaran K; Russell JW; Makar TK
    J Immunol; 2013 May; 190(9):4595-607. PubMed ID: 23547115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
    Ciftci O; Ozcan C; Kamisli O; Cetin A; Basak N; Aytac B
    Neurochem Res; 2015 Jun; 40(6):1111-20. PubMed ID: 25859982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity.
    Long T; Yang Y; Peng L; Li Z
    J Mol Neurosci; 2018 Feb; 64(2):233-241. PubMed ID: 29450696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
    Ji X; Liu H; An C; Wang Y; Zhao H; Zhang Q; Li M; Qi F; Chen Z; Wang X; Wang L
    J Ethnopharmacol; 2016 Jul; 187():123-33. PubMed ID: 27106785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
    Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
    Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
    Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Daru; 2015 Oct; 23():48. PubMed ID: 26489494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum [Met
    Ludwig MD; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
    Giralt M; Molinero A; Hidalgo J
    Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of catalpol in ameliorating the pathogenesis of experimental autoimmune encephalomyelitis by increasing the level of noradrenaline in the locus coeruleus.
    Li Q; Yang T; Guo AC; Fan YP
    Mol Med Rep; 2018 Mar; 17(3):4163-4172. PubMed ID: 29328415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
    Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
    J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.